Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.804 | 3.55e-15 | 6.98e-04 | 4.39e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
TGFB1 | 7040 | 2 | -1.997 | 2.821 | 60 | - | - |
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
TCP1 | 6950 | 10 | -2.383 | 3.119 | 241 | Yes | - |
MCRS1 | 10445 | 14 | -2.660 | 3.079 | 63 | Yes | Yes |
[ KRT33A ] | 3883 | 1 | -1.279 | 2.804 | 4 | - | - |
SYNCRIP | 10492 | 9 | -2.401 | 3.197 | 103 | Yes | Yes |
EPS15 | 2060 | 2 | -1.912 | 2.837 | 75 | - | - |
SH3BP4 | 23677 | 2 | -2.354 | 2.837 | 33 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
INO80E | 283899 | 10 | -2.663 | 3.079 | 20 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
ITSN2 | 50618 | 2 | -2.012 | 3.079 | 50 | Yes | - |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
NFRKB | 4798 | MCRS1 | 10445 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
SYNCRIP | 10492 | ITSN2 | 50618 | pp | -- | int.I2D: Jorgensen_EphR |
DDIT3 | 1649 | TCP1 | 6950 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPU | 3192 | SYNCRIP | 10492 | pp | -- | int.Mint: MI:0915(physical association) |
EPS15 | 2060 | TGFB1 | 7040 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
TCP1 | 6950 | SH3BP4 | 23677 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
EPS15 | 2060 | KRT33A | 3883 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
MCRS1 | 10445 | INO80E | 283899 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
PSMD2 | 5708 | TCP1 | 6950 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, YeastLow |
EPS15 | 2060 | ITSN2 | 50618 | pp | -- | int.I2D: Jorgensen_EphR |
MCRS1 | 10445 | ITSN2 | 50618 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
EPS15 | 2060 | SH3BP4 | 23677 | pp | -- | int.I2D: BIND, MINT; int.Mint: MI:0915(physical association) |
NFRKB | 4798 | INO80E | 283899 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0031011 | Ino80 complex | 3.29e-07 | 4.75e-03 | 7.687 | 3 | 6 | 14 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.01e-05 | 1.45e-01 | 8.587 | 2 | 2 | 5 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.51e-05 | 2.18e-01 | 8.324 | 2 | 3 | 6 |
GO:0006310 | DNA recombination | 3.82e-05 | 5.52e-01 | 5.472 | 3 | 7 | 65 |
GO:0005515 | protein binding | 4.46e-05 | 6.44e-01 | 1.160 | 14 | 198 | 6024 |
GO:0005654 | nucleoplasm | 4.94e-05 | 7.12e-01 | 2.637 | 7 | 64 | 1082 |
GO:0045662 | negative regulation of myoblast differentiation | 5.52e-05 | 7.97e-01 | 7.450 | 2 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.52e-05 | 7.97e-01 | 7.450 | 2 | 4 | 11 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 7.82e-05 | 1.00e+00 | 7.209 | 2 | 2 | 13 |
GO:0006897 | endocytosis | 1.65e-04 | 1.00e+00 | 4.766 | 3 | 7 | 106 |
GO:0006355 | regulation of transcription, DNA-templated | 3.13e-04 | 1.00e+00 | 2.533 | 6 | 43 | 997 |
GO:0044212 | transcription regulatory region DNA binding | 6.37e-04 | 1.00e+00 | 4.102 | 3 | 17 | 168 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0043090 | amino acid import | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0010742 | macrophage derived foam cell differentiation | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:1901666 | positive regulation of NAD+ ADP-ribosyltransferase activity | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0061035 | regulation of cartilage development | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 1 |
GO:0005905 | coated pit | 1.20e-03 | 1.00e+00 | 5.265 | 2 | 6 | 50 |
GO:0009611 | response to wounding | 1.30e-03 | 1.00e+00 | 5.209 | 2 | 5 | 52 |
GO:0006396 | RNA processing | 1.67e-03 | 1.00e+00 | 5.027 | 2 | 5 | 59 |
GO:0060242 | contact inhibition | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0045066 | regulatory T cell differentiation | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0060312 | regulation of blood vessel remodeling | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0032943 | mononuclear cell proliferation | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0046732 | active induction of host immune response by virus | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:1901203 | positive regulation of extracellular matrix assembly | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:2000628 | regulation of miRNA metabolic process | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0043932 | ossification involved in bone remodeling | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0019049 | evasion or tolerance of host defenses by virus | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 2 |
GO:0006281 | DNA repair | 2.27e-03 | 1.00e+00 | 3.466 | 3 | 14 | 261 |
GO:0071013 | catalytic step 2 spliceosome | 2.90e-03 | 1.00e+00 | 4.624 | 2 | 7 | 78 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0042306 | regulation of protein import into nucleus | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 2 | 3 |
GO:0060913 | cardiac cell fate determination | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0002513 | tolerance induction to self antigen | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0061462 | protein localization to lysosome | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 3 |
GO:0001649 | osteoblast differentiation | 4.00e-03 | 1.00e+00 | 4.386 | 2 | 5 | 92 |
GO:0010936 | negative regulation of macrophage cytokine production | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0060364 | frontal suture morphogenesis | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0007021 | tubulin complex assembly | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0010716 | negative regulation of extracellular matrix disassembly | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 4 |
GO:0031536 | positive regulation of exit from mitosis | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0007182 | common-partner SMAD protein phosphorylation | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0042482 | positive regulation of odontogenesis | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0051098 | regulation of binding | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0016202 | regulation of striated muscle tissue development | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0051101 | regulation of DNA binding | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 5 |
GO:0005634 | nucleus | 5.55e-03 | 1.00e+00 | 1.077 | 10 | 159 | 4559 |
GO:0030308 | negative regulation of cell growth | 5.67e-03 | 1.00e+00 | 4.128 | 2 | 6 | 110 |
GO:0030529 | ribonucleoprotein complex | 5.87e-03 | 1.00e+00 | 4.102 | 2 | 5 | 112 |
GO:0060744 | mammary gland branching involved in thelarche | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 6 |
GO:0085029 | extracellular matrix assembly | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 6 |
GO:0007435 | salivary gland morphogenesis | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 6 |
GO:0007050 | cell cycle arrest | 7.16e-03 | 1.00e+00 | 3.955 | 2 | 5 | 124 |
GO:0032930 | positive regulation of superoxide anion generation | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 7 |
GO:0050765 | negative regulation of phagocytosis | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 7 |
GO:0007184 | SMAD protein import into nucleus | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 7 |
GO:0005114 | type II transforming growth factor beta receptor binding | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 7 |
GO:0005092 | GDP-dissociation inhibitor activity | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 7 |
GO:0032801 | receptor catabolic process | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 7 |
GO:0070723 | response to cholesterol | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 7 |
GO:0001955 | blood vessel maturation | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0034616 | response to laminar fluid shear stress | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0010763 | positive regulation of fibroblast migration | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0007183 | SMAD protein complex assembly | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 8 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 9 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 1 | 9 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 5 | 9 |
GO:0006983 | ER overload response | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 1 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 9 |
GO:0005832 | chaperonin-containing T-complex | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 9 |
GO:0002199 | zona pellucida receptor complex | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 10 |
GO:0030122 | AP-2 adaptor complex | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 10 |
GO:0034260 | negative regulation of GTPase activity | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 10 |
GO:0006974 | cellular response to DNA damage stimulus | 1.05e-02 | 1.00e+00 | 3.671 | 2 | 7 | 151 |
GO:0022408 | negative regulation of cell-cell adhesion | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0070306 | lens fiber cell differentiation | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0016050 | vesicle organization | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0008354 | germ cell migration | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0006895 | Golgi to endosome transport | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 11 |
GO:0032740 | positive regulation of interleukin-17 production | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 1.22e-02 | 1.00e+00 | 3.552 | 2 | 15 | 164 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0008143 | poly(A) binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 12 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0019048 | modulation by virus of host morphology or physiology | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0002028 | regulation of sodium ion transport | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0048268 | clathrin coat assembly | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 13 |
GO:0030214 | hyaluronan catabolic process | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0050921 | positive regulation of chemotaxis | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 13 |
GO:0003714 | transcription corepressor activity | 1.43e-02 | 1.00e+00 | 3.433 | 2 | 11 | 178 |
GO:0033280 | response to vitamin D | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0030279 | negative regulation of ossification | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 14 |
GO:0032270 | positive regulation of cellular protein metabolic process | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0017016 | Ras GTPase binding | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0000242 | pericentriolar material | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 14 |
GO:0042307 | positive regulation of protein import into nucleus | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 4 | 15 |
GO:0043011 | myeloid dendritic cell differentiation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 15 |
GO:0035066 | positive regulation of histone acetylation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 15 |
GO:0032456 | endocytic recycling | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 15 |
GO:0043981 | histone H4-K5 acetylation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 5 | 15 |
GO:0001824 | blastocyst development | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 5 | 15 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.60e-02 | 1.00e+00 | 3.347 | 2 | 5 | 189 |
GO:0042176 | regulation of protein catabolic process | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 16 |
GO:0048535 | lymph node development | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 16 |
GO:0006796 | phosphate-containing compound metabolic process | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 17 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 17 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 17 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 17 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 1 | 17 |
GO:0006754 | ATP biosynthetic process | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 18 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 18 |
GO:0071158 | positive regulation of cell cycle arrest | 1.96e-02 | 1.00e+00 | 5.661 | 1 | 2 | 19 |
GO:0043984 | histone H4-K16 acetylation | 1.96e-02 | 1.00e+00 | 5.661 | 1 | 5 | 19 |
GO:0044822 | poly(A) RNA binding | 2.03e-02 | 1.00e+00 | 1.865 | 4 | 50 | 1056 |
GO:0071549 | cellular response to dexamethasone stimulus | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 3 | 20 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 20 |
GO:0032007 | negative regulation of TOR signaling | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 20 |
GO:0008156 | negative regulation of DNA replication | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 20 |
GO:0007492 | endoderm development | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 21 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 1 | 21 |
GO:0032967 | positive regulation of collagen biosynthetic process | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 3 | 21 |
GO:0043029 | T cell homeostasis | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 1 | 21 |
GO:0000123 | histone acetyltransferase complex | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 6 | 21 |
GO:0031593 | polyubiquitin binding | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 1 | 22 |
GO:0003823 | antigen binding | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 2 | 22 |
GO:0005720 | nuclear heterochromatin | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 2 | 22 |
GO:0060170 | ciliary membrane | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 1 | 22 |
GO:0010508 | positive regulation of autophagy | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.26e-02 | 1.00e+00 | 5.450 | 1 | 2 | 22 |
GO:0008380 | RNA splicing | 2.28e-02 | 1.00e+00 | 3.076 | 2 | 22 | 228 |
GO:0071346 | cellular response to interferon-gamma | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 23 |
GO:0000060 | protein import into nucleus, translocation | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 24 |
GO:0008134 | transcription factor binding | 2.55e-02 | 1.00e+00 | 2.990 | 2 | 18 | 242 |
GO:0006611 | protein export from nucleus | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 3 | 25 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 4 | 25 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 3 | 25 |
GO:0007339 | binding of sperm to zona pellucida | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 2 | 25 |
GO:0035329 | hippo signaling | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 5 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 3 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 26 |
GO:0048565 | digestive tract development | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 26 |
GO:0071339 | MLL1 complex | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 6 | 27 |
GO:0009314 | response to radiation | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 1 | 27 |
GO:0050714 | positive regulation of protein secretion | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 3 | 28 |
GO:0010467 | gene expression | 2.98e-02 | 1.00e+00 | 2.108 | 3 | 45 | 669 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 2.98e-02 | 1.00e+00 | 5.051 | 1 | 2 | 29 |
GO:0030501 | positive regulation of bone mineralization | 2.98e-02 | 1.00e+00 | 5.051 | 1 | 1 | 29 |
GO:0042130 | negative regulation of T cell proliferation | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 30 |
GO:0060325 | face morphogenesis | 3.18e-02 | 1.00e+00 | 4.955 | 1 | 1 | 31 |
GO:0042594 | response to starvation | 3.18e-02 | 1.00e+00 | 4.955 | 1 | 4 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 3.18e-02 | 1.00e+00 | 4.955 | 1 | 1 | 31 |
GO:0005829 | cytosol | 3.24e-02 | 1.00e+00 | 1.209 | 6 | 86 | 2496 |
GO:0003677 | DNA binding | 3.25e-02 | 1.00e+00 | 1.659 | 4 | 49 | 1218 |
GO:0006954 | inflammatory response | 3.27e-02 | 1.00e+00 | 2.795 | 2 | 6 | 277 |
GO:0032570 | response to progesterone | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 32 |
GO:0043491 | protein kinase B signaling | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 32 |
GO:0002062 | chondrocyte differentiation | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 32 |
GO:0001837 | epithelial to mesenchymal transition | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 33 |
GO:0045599 | negative regulation of fat cell differentiation | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 2 | 35 |
GO:0042552 | myelination | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 35 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 36 |
GO:0001933 | negative regulation of protein phosphorylation | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 36 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 3 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.78e-02 | 1.00e+00 | 4.700 | 1 | 5 | 37 |
GO:0048839 | inner ear development | 3.78e-02 | 1.00e+00 | 4.700 | 1 | 1 | 37 |
GO:0005902 | microvillus | 3.88e-02 | 1.00e+00 | 4.661 | 1 | 3 | 38 |
GO:0001657 | ureteric bud development | 3.88e-02 | 1.00e+00 | 4.661 | 1 | 2 | 38 |
GO:0097191 | extrinsic apoptotic signaling pathway | 3.88e-02 | 1.00e+00 | 4.661 | 1 | 1 | 38 |
GO:0071407 | cellular response to organic cyclic compound | 3.88e-02 | 1.00e+00 | 4.661 | 1 | 3 | 38 |
GO:0045786 | negative regulation of cell cycle | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 3 | 39 |
GO:0035019 | somatic stem cell maintenance | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 6 | 40 |
GO:0017148 | negative regulation of translation | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 2 | 40 |
GO:0030136 | clathrin-coated vesicle | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 5 | 42 |
GO:0071230 | cellular response to amino acid stimulus | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 1 | 42 |
GO:0008283 | cell proliferation | 4.45e-02 | 1.00e+00 | 2.552 | 2 | 14 | 328 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.53e-02 | 1.00e+00 | 1.870 | 3 | 41 | 789 |
GO:0044297 | cell body | 4.68e-02 | 1.00e+00 | 4.386 | 1 | 2 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 4.68e-02 | 1.00e+00 | 4.386 | 1 | 4 | 46 |
GO:0043406 | positive regulation of MAP kinase activity | 4.68e-02 | 1.00e+00 | 4.386 | 1 | 2 | 46 |
GO:0003723 | RNA binding | 4.80e-02 | 1.00e+00 | 2.491 | 2 | 18 | 342 |
GO:0005070 | SH3/SH2 adaptor activity | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 2 | 48 |
GO:0031093 | platelet alpha granule lumen | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 2 | 48 |
GO:0043565 | sequence-specific DNA binding | 4.90e-02 | 1.00e+00 | 2.475 | 2 | 11 | 346 |
GO:0001669 | acrosomal vesicle | 4.98e-02 | 1.00e+00 | 4.294 | 1 | 2 | 49 |
GO:0016049 | cell growth | 4.98e-02 | 1.00e+00 | 4.294 | 1 | 3 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 4 | 50 |
GO:0031100 | organ regeneration | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 1 | 50 |
GO:0001948 | glycoprotein binding | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 2 | 50 |
GO:0008285 | negative regulation of cell proliferation | 5.08e-02 | 1.00e+00 | 2.446 | 2 | 10 | 353 |
GO:0030334 | regulation of cell migration | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 5 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 5.18e-02 | 1.00e+00 | 4.237 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 5.18e-02 | 1.00e+00 | 4.237 | 1 | 1 | 51 |
GO:0050680 | negative regulation of epithelial cell proliferation | 5.18e-02 | 1.00e+00 | 4.237 | 1 | 2 | 51 |
GO:0045216 | cell-cell junction organization | 5.47e-02 | 1.00e+00 | 4.154 | 1 | 2 | 54 |
GO:0002244 | hematopoietic progenitor cell differentiation | 5.47e-02 | 1.00e+00 | 4.154 | 1 | 1 | 54 |
GO:0050679 | positive regulation of epithelial cell proliferation | 5.47e-02 | 1.00e+00 | 4.154 | 1 | 2 | 54 |
GO:0009967 | positive regulation of signal transduction | 5.67e-02 | 1.00e+00 | 4.102 | 1 | 1 | 56 |
GO:0046982 | protein heterodimerization activity | 5.80e-02 | 1.00e+00 | 2.339 | 2 | 8 | 380 |
GO:0000502 | proteasome complex | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 3 | 58 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 5.97e-02 | 1.00e+00 | 4.027 | 1 | 2 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 5.97e-02 | 1.00e+00 | 4.027 | 1 | 6 | 59 |
GO:0005089 | Rho guanyl-nucleotide exchange factor activity | 5.97e-02 | 1.00e+00 | 4.027 | 1 | 1 | 59 |
GO:0005882 | intermediate filament | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 2 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 2 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 2 | 61 |
GO:0009986 | cell surface | 6.41e-02 | 1.00e+00 | 2.258 | 2 | 9 | 402 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 1 | 64 |
GO:0009749 | response to glucose | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 7 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 2 | 65 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.72e-02 | 1.00e+00 | 2.219 | 2 | 24 | 413 |
GO:0010468 | regulation of gene expression | 6.85e-02 | 1.00e+00 | 3.822 | 1 | 2 | 68 |
GO:0006366 | transcription from RNA polymerase II promoter | 6.89e-02 | 1.00e+00 | 2.198 | 2 | 30 | 419 |
GO:0050790 | regulation of catalytic activity | 6.94e-02 | 1.00e+00 | 3.801 | 1 | 1 | 69 |
GO:0005737 | cytoplasm | 6.98e-02 | 1.00e+00 | 0.837 | 7 | 124 | 3767 |
GO:0006874 | cellular calcium ion homeostasis | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 2 | 70 |
GO:0051897 | positive regulation of protein kinase B signaling | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 2 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 2 | 70 |
GO:0032355 | response to estradiol | 7.14e-02 | 1.00e+00 | 3.759 | 1 | 3 | 71 |
GO:0000165 | MAPK cascade | 7.24e-02 | 1.00e+00 | 3.739 | 1 | 2 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.24e-02 | 1.00e+00 | 3.739 | 1 | 1 | 72 |
GO:0005796 | Golgi lumen | 7.24e-02 | 1.00e+00 | 3.739 | 1 | 3 | 72 |
GO:0002020 | protease binding | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 6 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.43e-02 | 1.00e+00 | 3.700 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 7.53e-02 | 1.00e+00 | 3.680 | 1 | 1 | 75 |
GO:0031901 | early endosome membrane | 7.53e-02 | 1.00e+00 | 3.680 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.53e-02 | 1.00e+00 | 3.680 | 1 | 1 | 75 |
GO:0010629 | negative regulation of gene expression | 7.72e-02 | 1.00e+00 | 3.642 | 1 | 4 | 77 |
GO:0007565 | female pregnancy | 7.82e-02 | 1.00e+00 | 3.624 | 1 | 2 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 7.91e-02 | 1.00e+00 | 3.605 | 1 | 2 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.91e-02 | 1.00e+00 | 3.605 | 1 | 2 | 79 |
GO:0002576 | platelet degranulation | 8.20e-02 | 1.00e+00 | 3.552 | 1 | 2 | 82 |
GO:0032321 | positive regulation of Rho GTPase activity | 8.20e-02 | 1.00e+00 | 3.552 | 1 | 1 | 82 |
GO:0009653 | anatomical structure morphogenesis | 8.30e-02 | 1.00e+00 | 3.534 | 1 | 2 | 83 |
GO:0006464 | cellular protein modification process | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 4 | 84 |
GO:0044267 | cellular protein metabolic process | 8.54e-02 | 1.00e+00 | 2.020 | 2 | 20 | 474 |
GO:0047485 | protein N-terminus binding | 8.58e-02 | 1.00e+00 | 3.483 | 1 | 3 | 86 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 8.58e-02 | 1.00e+00 | 3.483 | 1 | 8 | 86 |
GO:0045893 | positive regulation of transcription, DNA-templated | 8.66e-02 | 1.00e+00 | 2.008 | 2 | 24 | 478 |
GO:0016020 | membrane | 8.80e-02 | 1.00e+00 | 1.194 | 4 | 46 | 1681 |
GO:0042802 | identical protein binding | 8.85e-02 | 1.00e+00 | 1.990 | 2 | 19 | 484 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 9.16e-02 | 1.00e+00 | 3.386 | 1 | 1 | 92 |
GO:0051082 | unfolded protein binding | 9.25e-02 | 1.00e+00 | 3.370 | 1 | 7 | 93 |
GO:0005770 | late endosome | 9.25e-02 | 1.00e+00 | 3.370 | 1 | 2 | 93 |
GO:0001934 | positive regulation of protein phosphorylation | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 5 | 104 |
GO:0005509 | calcium ion binding | 1.04e-01 | 1.00e+00 | 1.857 | 2 | 11 | 531 |
GO:0016032 | viral process | 1.05e-01 | 1.00e+00 | 1.848 | 2 | 26 | 534 |
GO:0072562 | blood microparticle | 1.09e-01 | 1.00e+00 | 3.115 | 1 | 3 | 111 |
GO:0017124 | SH3 domain binding | 1.11e-01 | 1.00e+00 | 3.089 | 1 | 1 | 113 |
GO:0019058 | viral life cycle | 1.13e-01 | 1.00e+00 | 3.064 | 1 | 1 | 115 |
GO:0000209 | protein polyubiquitination | 1.14e-01 | 1.00e+00 | 3.051 | 1 | 3 | 116 |
GO:0007568 | aging | 1.15e-01 | 1.00e+00 | 3.039 | 1 | 2 | 117 |
GO:0006325 | chromatin organization | 1.16e-01 | 1.00e+00 | 3.027 | 1 | 12 | 118 |
GO:0006260 | DNA replication | 1.19e-01 | 1.00e+00 | 2.990 | 1 | 3 | 121 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.22e-01 | 1.00e+00 | 2.955 | 1 | 5 | 124 |
GO:0030335 | positive regulation of cell migration | 1.24e-01 | 1.00e+00 | 2.921 | 1 | 5 | 127 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 11 | 128 |
GO:0016055 | Wnt signaling pathway | 1.34e-01 | 1.00e+00 | 2.801 | 1 | 4 | 138 |
GO:0005125 | cytokine activity | 1.34e-01 | 1.00e+00 | 2.801 | 1 | 2 | 138 |
GO:0008083 | growth factor activity | 1.37e-01 | 1.00e+00 | 2.770 | 1 | 3 | 141 |
GO:0006457 | protein folding | 1.39e-01 | 1.00e+00 | 2.749 | 1 | 7 | 143 |
GO:0010628 | positive regulation of gene expression | 1.42e-01 | 1.00e+00 | 2.719 | 1 | 7 | 146 |
GO:0001666 | response to hypoxia | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 7 | 149 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 3 | 149 |
GO:0005198 | structural molecule activity | 1.45e-01 | 1.00e+00 | 2.680 | 1 | 3 | 150 |
GO:0042981 | regulation of apoptotic process | 1.45e-01 | 1.00e+00 | 2.680 | 1 | 4 | 150 |
GO:0005578 | proteinaceous extracellular matrix | 1.54e-01 | 1.00e+00 | 2.587 | 1 | 4 | 160 |
GO:0030424 | axon | 1.59e-01 | 1.00e+00 | 2.534 | 1 | 4 | 166 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.63e-01 | 1.00e+00 | 1.460 | 2 | 39 | 699 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.64e-01 | 1.00e+00 | 2.491 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 1.67e-01 | 1.00e+00 | 2.458 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.70e-01 | 1.00e+00 | 2.433 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.75e-01 | 1.00e+00 | 2.386 | 1 | 22 | 184 |
GO:0030168 | platelet activation | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 6 | 205 |
GO:0016071 | mRNA metabolic process | 2.09e-01 | 1.00e+00 | 2.108 | 1 | 8 | 223 |
GO:0003713 | transcription coactivator activity | 2.20e-01 | 1.00e+00 | 2.020 | 1 | 24 | 237 |
GO:0043025 | neuronal cell body | 2.27e-01 | 1.00e+00 | 1.973 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 2.28e-01 | 1.00e+00 | 1.961 | 1 | 8 | 247 |
GO:0005874 | microtubule | 2.30e-01 | 1.00e+00 | 1.949 | 1 | 7 | 249 |
GO:0070062 | extracellular vesicular exosome | 2.31e-01 | 1.00e+00 | 0.680 | 4 | 57 | 2400 |
GO:0000166 | nucleotide binding | 2.38e-01 | 1.00e+00 | 1.892 | 1 | 13 | 259 |
GO:0005730 | nucleolus | 2.39e-01 | 1.00e+00 | 0.814 | 3 | 66 | 1641 |
GO:0043065 | positive regulation of apoptotic process | 2.45e-01 | 1.00e+00 | 1.843 | 1 | 7 | 268 |
GO:0019899 | enzyme binding | 2.53e-01 | 1.00e+00 | 1.795 | 1 | 9 | 277 |
GO:0030198 | extracellular matrix organization | 2.57e-01 | 1.00e+00 | 1.765 | 1 | 6 | 283 |
GO:0042493 | response to drug | 2.58e-01 | 1.00e+00 | 1.759 | 1 | 6 | 284 |
GO:0005615 | extracellular space | 2.62e-01 | 1.00e+00 | 1.007 | 2 | 20 | 957 |
GO:0043231 | intracellular membrane-bounded organelle | 2.84e-01 | 1.00e+00 | 1.596 | 1 | 6 | 318 |
GO:0005813 | centrosome | 2.90e-01 | 1.00e+00 | 1.560 | 1 | 7 | 326 |
GO:0015031 | protein transport | 3.02e-01 | 1.00e+00 | 1.496 | 1 | 11 | 341 |
GO:0008284 | positive regulation of cell proliferation | 3.32e-01 | 1.00e+00 | 1.332 | 1 | 10 | 382 |
GO:0000278 | mitotic cell cycle | 3.38e-01 | 1.00e+00 | 1.298 | 1 | 15 | 391 |
GO:0043066 | negative regulation of apoptotic process | 3.61e-01 | 1.00e+00 | 1.181 | 1 | 16 | 424 |
GO:0007596 | blood coagulation | 3.82e-01 | 1.00e+00 | 1.079 | 1 | 11 | 455 |
GO:0006468 | protein phosphorylation | 3.85e-01 | 1.00e+00 | 1.064 | 1 | 10 | 460 |
GO:0005524 | ATP binding | 3.97e-01 | 1.00e+00 | 0.567 | 2 | 31 | 1298 |
GO:0006915 | apoptotic process | 4.45e-01 | 1.00e+00 | 0.793 | 1 | 12 | 555 |
GO:0005783 | endoplasmic reticulum | 4.46e-01 | 1.00e+00 | 0.790 | 1 | 13 | 556 |
GO:0006351 | transcription, DNA-templated | 4.52e-01 | 1.00e+00 | 0.411 | 2 | 57 | 1446 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.54e-01 | 1.00e+00 | 0.754 | 1 | 37 | 570 |
GO:0042803 | protein homodimerization activity | 4.69e-01 | 1.00e+00 | 0.692 | 1 | 19 | 595 |
GO:0005794 | Golgi apparatus | 4.77e-01 | 1.00e+00 | 0.657 | 1 | 9 | 610 |
GO:0005576 | extracellular region | 6.37e-01 | 1.00e+00 | 0.030 | 1 | 13 | 942 |
GO:0044281 | small molecule metabolic process | 7.32e-01 | 1.00e+00 | -0.333 | 1 | 20 | 1211 |
GO:0005886 | plasma membrane | 7.79e-01 | 1.00e+00 | -0.425 | 2 | 49 | 2582 |